MFDS added blood clots to the precautions for AZ vaccine

By Lee, Tak-Sun | translator Choi HeeYoung

21.04.27 15:09:33

가나다라 0

The Central Pharmaceutical Affairs Review Committee determined that there was a causal relationship between the vaccine and the adverse reaction. Experts said that attention should be paid

A specific thrombosis with thrombocytopenia was added to the precautions for using the AstraZeneca COVID-19 vaccine. For this adverse reaction, the MFDS also recognized the causality with the vaccine.

The MFDS announced on the 27th that it changed the precautions for use after consulting experts on the case of blood clots that occurred after vaccination with AstraZeneca COVID-19 vaccine.

On the 8th, the MFDS issued a safety letter regarding a specific thrombosis with thrombocytopenia of the AstraZeneca COVID-19 vaccine. It is explained that additional necessary measures have been reviewed.

Through the Central Pharmaceutical Affairs Review Committee meeting on the 20th, the

Lee, Tak-Sun(hooggasi2@dailypharm.com)

If you want to see the full article, please JOIN US (click)